Respiratory Diagnosis Treatment Articles & Analysis
15 news found
Recent advances in the fight against severe acute inflammatory lung diseases, including COVID-19, have revealed a promising new approach to treating pulmonary hyperinflammation and long-term lung damage such as fibrosis. A groundbreaking study has developed a first-in-class, carbohydrate-coupled inhibitor of microRNA-21 (RCS-21), which shows significant potential as a therapeutic agent. This ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening critical care conditions, announced today that it has been awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH). Funding from the grant will be used to further the development of ENA001, Enalare's ...
Broncholab™, developed and implemented by Fluidda, is a platform where CT-scan data of individual persons can be uploaded and analyzed with FRI-technology. The result of this analysis is then sent to the attending physician alone, observing all privacy requirements. Broncholab provides physicians with reproducible CT values for pulmonary tissue for providing quantitative support for ...
ByFluidda
Milan, January 27, 2022 – InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announces the closing of its Series C financing with granting an exclusive licensing agreement to Grand Pharmaceutical Group Limited, (Grand Pharma) for its proprietary Saturn device in Greater China. The transaction pulled in ...
Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma (“Nuance”), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening ...
ByAerogen
(https://intin.kr/en/) has been recently honored with the 'Innovation Award' from CES (Consumer Electronics Show) for its 'Oview Multi Device' product, a respiratory diagnosis and treatment system. CES is the world's biggest & influential tech event, held annually in the USA. ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening critical care conditions, announced today that it has been invited to present at the BARDA Industry Day being held virtually Nov. 3-4, 2021. The Biomedical Advanced Research and Development Authority (BARDA) is a component of the Office of the Assistant ...
US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance in connection with JCRI-ABTS’s US National Stage Application (Serial No. 17/284,762) entitled “SYSTEM FOR TREATMENT OF RESPIRATORY INFECTIONS AND ...
MD Tech Review, a premier medical innovation magazine, has voted MediPines as a 2020 Top Ten Patient Monitoring Solution Provider. MediPines’ innovative respiratory technology, AGM100®, is making a positive impact in hospitals battling Covid-19. This industry recognition came about as MediPines introduced the AGM100®, an advanced respiratory monitoring system, commercially in the ...
OM Pharma enters into a strategic collaboration agreement granting AstraZeneca the exclusive right to import and distribute the immunological therapy Broncho-Vaxom® for the prevention and treatment of respiratory tract infections in China (excluding Hong Kong, Macau, and Taiwan). OM Pharma and AstraZeneca celebrated their strategic collaboration agreement today at a partnership signing ...
Espoo Health Services was well prepared for the expansion of the corona epidemic and reorganized its operations. One of the tasks was to change the Samaria health station in the center of Espoo, Finland, into an infection center focusing on the treatment of respiratory infections. In the next phase, another health station was prepared for similar use in case the first infection center's ...
Yaguo Fight against the Epidemic!! Once again Yaguo have made a donation in order to support the frontline of the epidemic, helping with their innovating products that brings out intensive care and rehabilitation. On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal ...
Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). ...
ByKoura
Allovate Therapeutics (“Allovate®”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce the appointment of Robert "Bob" Pomrenke to the position of Chief Executive Officer, effective April 1, 2019. Mr. Pomrenke brings over 25 years of sales, marketing and business development experience in the allergy immunotherapy market. ...
Allovate Therapeutics, a biopharmaceutical company focused on improving treatment for allergies, announced today that the U.S Patent and Trademark Office (USPTO) has granted U.S. Patent No. 9,271,899 entitled, “Methods, Articles and Kits for Allergic Desensitization, via the Oral Mucosa.” The issuing patent including claims to the approach of combining allergenic proteins with ...